An A10398G mitochondrial DNA alteration is related to increased risk of breast cancer, and associates with Her2 positive receptor

References

• Agnese DM, Pollock RE. 2016. Breast cancer genetic counseling: a surgeon’s perspective. Front Surg. 3:4.
   PubMed Web of Science ®Google Scholar
• Akouchekian M, Houshmand M, Akbari MH, Kamalidehghan B, Dehghan M. 2011. Analysis of mitochondrial ND1 gene in human colorectal cancer. J Res Med Sci. 16(1):50–55.
   PubMed Web of Science ®Google Scholar
• Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. 2007. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 67(10):4687–4694.
   PubMed Web of Science ®Google Scholar
• Cai FF, Kohler C, Zhang B, Chen WJ, Barekati Z, Garritsen HS, Lenner P, Toniolo P, Zhang JJ, Zhong XY. 2011. Mutations of mitochondrial DNA as potential biomarkers in breast cancer. Anticancer Res. 31(12):4267–4271.
   PubMed Web of Science ®Google Scholar
• Canter JA, Kallianpur AR, Parl FF, Millikan RC. 2005. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65(17):8028–8033.
   PubMed Web of Science ®Google Scholar
• Chinnery PF. 2000. [Updated 2010]. Mitochondrial disorders overview. In: Adam MP, Pagon RA, Ardinger HH. editors. GeneReviews®. Seattle: University of Washington.
   Google Scholar
• Covarrubias D, Bai RK, Wong LJ, Leal SM. 2008. Mitochondrial DNA variant interactions modify breast cancer risk. J Hum Genet. 53(10):924–928.
   PubMed Web of Science ®Google Scholar
• Czarnecka AM, Klemba A, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E, Petros JA. 2010. Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep. 23(2):531–535.
   PubMed Web of Science ®Google Scholar
• Czarnecka AM, Krawczyk T, Plak K, Klemba A, Zdrozny M, Arnold RS, Kofler B, Golik P, Szybinska A, Lubinski J, et al. 2010. Mitochondrial genotype and breast cancer predisposition. Oncol Rep. 24(6):1521–1534.
   PubMed Web of Science ®Google Scholar
• Czarnecka AM, Krawczyk T, Zdrożny M, Lubiński J, Arnold RS, Kukwa W, Ścińska A, Golik P, Bartnik E, Petros JA. 2010. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat. 121(2):511–518.
   PubMed Web of Science ®Google Scholar
• Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. 2007. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 249(2):249–255.
   PubMed Web of Science ®Google Scholar
• Elster N, Collins DM, Toomey S, Crown J, Eustace AJ, Hennessy BT. 2015. HER2-family signalling mechanisms, clinical implications and targeting in breast cancer. Breast Cancer Res Treat. 149(1):5–15.
   PubMed Web of Science ®Google Scholar
• Fang H, Shen L, Chen T, He J, Ding Z, Wei J, Qu J, Chen G, Lu J, Bai Y. 2010. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer. 10(1):421.
   PubMedGoogle Scholar
• Gutierrez Povedano C, Salgado J, Gil C, Robles M, Patino-Garcia A, Garcia-Foncillas J. 2015. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer. Mitochondrial DNA. 26:227–231.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Tseng LM, Lee HC. 2016. Role of mitochondrial dysfunction in cancer progression. Exp Biol Med. 241(12):1281–1295.
   PubMed Web of Science ®Google Scholar
• Hu L, Yao X, Shen Y. 2016. Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis. Sci Rep. 6(1):35859.
   PubMedGoogle Scholar
• Ishikawa K, Hayashi J. 2010. A novel function of mtDNA: its involvement in metastasis. Ann N Y Acad Sci. 1201:40–43.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320(5876):661–664.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhao H, Xu H, Hu L, Wang W, Wei Y, Wang Y, Peng X, Zhou F. 2014. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population. Cancer Sci. 105(6):639–645.
   PubMed Web of Science ®Google Scholar
• Kannan A, Wells RB, Sivakumar S, Komatsu S, Singh KP, Samten B, Philley JV, Sauter ER, Ikebe M, Idell S, et al. 2016. Mitochondrial reprogramming regulates breast cancer progression. Clin Cancer Res. 22(13):3348–3360.
   PubMed Web of Science ®Google Scholar
• Kumler I, Tuxen MK, Nielsen DL. 2014. A systematic review of dual targeting in HER2-positive breast cancer. Cancer Treat Rev. 40:259–270.
   PubMed Web of Science ®Google Scholar
• Lee H, Geng C, Cheng M, Lee Z, Guo Z. 2016. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of familial breast cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 27:3082–3085.
   PubMedGoogle Scholar
• Li CT, Bai YM, Hsieh JC, Lee HC, Yang BH, Chen MH, Lin WC, Tsai CF, Tu PC, Wang SJ, et al. 2015. Peripheral and central glucose utilizations modulated by mitochondrial DNA 10398A in bipolar disorder. Psychoneuroendocrinology. 55:72–80.
   PubMed Web of Science ®Google Scholar
• Li L, Chen L, Li J, Zhang W, Liao Y, Chen J, Sun Z. 2016. Correlational study on mitochondrial DNA mutations as potential risk factors in breast cancer. Oncotarget. 7:31270–31283.
   PubMedGoogle Scholar
• Liou CW, Chen JB, Tiao MM, Weng SW, Huang TL, Chuang JH, Chen SD, Chuang YC, Lee WC, Lin TK, et al. 2012. Mitochondrial DNA coding and control region variants as genetic risk factors for type 2 diabetes. Diabetes. 61(10):2642–2651.
   PubMed Web of Science ®Google Scholar
• Lott MT, Leipzig JN, Derbeneva O, Xie HM, Chalkia D, Sarmady M, Procaccio V, Wallace DC. 2013. mtDNA variation and analysis using Mitomap and Mitomaster. Curr Protoc Bioinformatics. 44:1 23 1–26.
   PubMedGoogle Scholar
• Maximo V, Lima J, Soares P, Sobrinho-Simoes M. 2009. Mitochondria and cancer. Virchows Arch. 454(5):481–495.
   PubMed Web of Science ®Google Scholar
• McMahon S, LaFramboise T. 2014. Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis. 35(5):1046–1054.
   PubMed Web of Science ®Google Scholar
• Polyak K. 2011. Heterogeneity in breast cancer. J Clin Invest. 121(10):3786–3788.
   PubMed Web of Science ®Google Scholar
• Rohan TE, Wong LJ, Wang T, Haines J, Kabat GC. 2010. Do alterations in mitochondrial DNA play a role in breast carcinogenesis?. J Oncol. 2010:604304
   PubMedGoogle Scholar
• Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, LeBoeuf SE, Gay LJ, Yagi T, Felding-Habermann B. 2013. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest. 123(3):1068–1081.
   PubMed Web of Science ®Google Scholar
• Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, Press MF, Ursin G, Haiman CA, Neuhausen SL. 2008. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet Cytogenet. 181(1):16–19.
   PubMedGoogle Scholar
• Sharifian A, Pourhoseingholi MA, Emadedin M, Rostami Nejad M, Ashtari S, Hajizadeh N, Firouzei SA, Hosseini SJ. 2015. Burden of breast cancer in Iranian women is increasing. Asian Pac J Cancer Prev. 16(12):5049–5052.
   PubMedGoogle Scholar
• Sultana GNN, Rahman A, Manjurul Karim M, Shahinuzzaman ADA, Begum R, Begum RA. 2011. Breast cancer risk associated mitochondrial NADH-dehydrogenase subunit-3 (ND3) polymorphisms (G10398A and T10400C) in Bangladeshi women. J Med Genet Genomics. 3:131–135.
   Google Scholar
• Tan DJ, Bai RK, Wong LJ. 2002. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 62(4):972–976.
   PubMed Web of Science ®Google Scholar
• Tengku Baharudin N, Jaafar H, Zainuddin Z. 2012. Association of mitochondrial DNA 10398 polymorphism in invasive breast cancer in malay population of peninsular malaysia. Malays J Med Sci. 19:36–42.
   PubMedGoogle Scholar
• Vyas S, Zaganjor E, Haigis MC. 2016. Mitochondria and Cancer. Cell. 166(3):555–566.
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, et al. 2014. Mass-spectrometry-based draft of the human proteome. Nature. 509(7502):582–587.
   PubMed Web of Science ®Google Scholar
• Yu Y, Lv F, Lin H, Qian G, Jiang YS, Pang LX, Wang YP, Wang XF, Kang YM, Li CB, et al. 2015. Mitochondrial ND3 G10398A mutation: a biomarker for breast cancer. Genet Mol Res. 14(4):17426–17431.
   PubMed Web of Science ®Google Scholar